Articles From: USA Technologies Introduces ePort Mobile as a Turnkey Solution for B2B and B2C Transactions at 2013 ETA Annual Meeting and Expo to Webcast Alert: Isis Pharmaceuticals' First Quarter 2013 Financial Results Conference Call


2013/5/2
USA Technologies, Inc. (NASDAQ: USAT) (“USAT”), a leader of wireless, cashless payment and M2M telemetry solutions for small-ticket, self-serve retailing industries is showcasing ePort Mobile TM —an extension of USAT’s flagship ePort Connect® service—at the 2013 ETA Annual Meeting & Expo , at the New Orleans Convention Center in New Orleans.
Sign-up for USA Technologies Introduces ePort Mobile as a Turnkey Solution for B2B and B2C Transactions at 2013 ETA Annual Meeting and Expo investment picks
2013/5/2
Company Welcomes Tyler McGill, Karina Bryant and Crystal Manning to Team USANA SALT LAKE CITY , May 2, 2013 /PRNewswire/ --  USANA Health Sciences Inc. (NYSE: USNA) , a global nutritional supplements company, has partnered with Summer Game medalists swimmer Tyler McGill ( United States ) and mixed martial artist Karina Bryant (judo, Great Britain ), as well as track and field star Crystal Manning (triple jump, United States ). Team USANA's newest members join more than 600 world-class athletes who take USANA's NSF and HFL- tested nutritional products .
Sign-up for USANA Health Sciences Partners With Summer Games Athletes investment picks
2013/5/2
Recognized with over 100 awards, the official website for the State of Utah ( http://Utah.gov ), shows off a new homepage boasting major enhancements.
Sign-up for Utah.gov Does It Again investment picks
2013/5/2
Valeant Pharmaceuticals Provides Efinconazole Update Canada NewsWire LAVAL, Quebec , May 2, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that we agreed this afternoon that the launch of efinaconazole, our topical product candidate for the treatment of onychomycosis, will not occur until after the September 2013 arbitration hearing to resolve the breach of contract dispute with Anacor Pharmaceuticals (NASDAQ: ANAC) .
Sign-up for Valeant Pharmaceuticals Provides Efinconazole Update investment picks
2013/5/2
LAVAL, Quebec , May 2, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that we agreed this afternoon that the launch of efinaconazole, our topical product candidate for the treatment of onychomycosis, will not occur until after the September 2013 arbitration hearing to resolve the breach of contract dispute with Anacor Pharmaceuticals (NASDAQ: ANAC) .
Sign-up for Valeant Pharmaceuticals Provides Efinconazole Update investment picks
2013/5/2
LAVAL, Quebec , May 2, 2013 /PRNewswire/ --   2013 First Quarter Total Revenue $1.068 billion ; an increase of 25% over the prior year   2013 First Quarter Product Sales $1.039 billion ; an increase of 38% over the prior year   Organic growth (same store sales) was 6%, excluding the impact from generics, primarily BenzaClin and Cesamet   Pro forma organic growth was 4%, excluding the impact from generics, primarily BenzaClin and Cesamet   2013 First Quarter GAAP EPS Loss of $0.09 ; Cash EPS $1.30 , an increase of 43% over the prior year, excluding one-time items in 2012 first quarter   2013 First Quarter GAAP Operating Cash Flow $255 million ; Adjusted Operating Cash Flow $345 million ; an increase of 35% over the prior year, excluding one-time items in 2012 first quarter   2013 Guidance for Cash EPS raised to $5.55 to $5.85 despite entry of Zovirax generic ointment Valeant Pharmaceuticals International,
Sign-up for Valeant Pharmaceuticals Reports 2013 First Quarter Financial Results investment picks
2013/5/2
Valeant Pharmaceuticals Reports 2013 First Quarter Financial Results Canada NewsWire LAVAL, Quebec, May 2, 2013 /CNW/ - 2013 First Quarter Total Revenue $1.068 billion; an increase of 25% over the prior year 2013 First Quarter Product Sales $1.039 billion; an increase of 38% over the prior year Organic growth (same store sales) was 6%, excluding the impact from generics, primarily BenzaClin and Cesamet Pro forma organic growth was 4%, excluding the impact from generics, primarily BenzaClin and Cesamet 2013 First Quarter GAAP EPS Loss of $0.09; Cash EPS $1.30, an increase of 43% over the prior year, excluding one-time items in 2012 first quarter 2013 First Quarter GAAP Operating Cash Flow $255 million; Adjusted Operating Cash Flow $345 million; an increase of 35% over the prior year, excluding one-time items in 2012 first quarter 2013 Guidance for Cash EPS raised to $5.55 to $5.85 despite entry of Zovirax generic
Sign-up for Valeant Pharmaceuticals Reports 2013 First Quarter Financial Results investment picks
2013/5/2
Valeant Pharmaceuticals International Inc.'s (VRX) first-quarter loss widened, but excluding one-time items, results beat analyst expectations and the company hiked its earnings guidance for the year.
Sign-up for Valeant Posts 1st-Quarter Loss; Adjusted Earnings Beat investment picks
2013/5/2
SAN DIEGO , May 2, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM) , a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it will release first quarter 2013 financial results on Thursday, May 9, 2013 after market close.
Sign-up for Verenium Corporation to Announce First Quarter 2013 Financial Results investment picks
2013/5/2
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.
Sign-up for VERIFONE SYSTEMS 96 HOUR ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Lead Plaintiff Motion Deadline in Securities Class Action Lawsuit against VeriFone Systems, Inc. investment picks
2013/5/2
Verint ® Systems Inc. (NASDAQ: VRNT) today announced its participation in two upcoming investor conferences.
Sign-up for Verint Announces Participation in Upcoming Investor Conferences investment picks
2013/5/2
TULSA, Okla.
Sign-up for Verizon Communications Reports on Preliminary Shareholder Vote Results at Annual Meeting investment picks
2013/5/2
CALGARY , May 2, 2013 /PRNewswire/ - Vermilion Energy Inc. (the "Company") (TSX:VET) (NYSE:VET) is pleased to report that at its annual and special meeting of shareholders held on May 1, 2013 each of the eight nominees proposed as directors and listed in its proxy statement and information circular dated April 2, 2013 , were elected as directors of the Company.
Sign-up for Vermilion Energy Inc. Reports Voting Results of Election of Directors investment picks
2013/5/2
Vermilion Energy Inc. Reports Voting Results of Election of Directors Canada NewsWire CALGARY , May 2, 2013 /CNW/ - Vermilion Energy Inc. (the "Company") (TSX:VET) (NYSE:VET) is pleased to report that at its annual and special meeting of shareholders held on May 1, 2013 each of the eight nominees proposed as directors and listed in its proxy statement and information circular dated April 2, 2013 , were elected as directors of the Company.
Sign-up for Vermilion Energy Inc. Reports Voting Results of Election of Directors investment picks
2013/5/2
CARLSBAD, Calif.
Sign-up for ViaSat Adds Robert Bowman to Board of Directors investment picks
2013/5/2
SAN DIEGO, May 2, 2013 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three months ended March 31, 2013, before the opening of trading on Thursday, May 9, and conduct a conference call and webcast to discuss the financial results and provide a company update at noon Eastern Time on Thursday, May 9.
Sign-up for Vical Announces News Release and Conference Call Schedule for First Quarter 2013 Financial Results investment picks
2013/5/2
Virtual Piggy, Inc. (OTCBB: VPIG) , an innovator in safe youth payments, is proud to announce that they are the winners of The National Parenting Center’s 2013 Seal of Approval under the Websites category.
Sign-up for Virtual Piggy is a 2013 Seal of Approval Winner investment picks
2013/5/2
FOSTER CITY, Calif.
Sign-up for Visa Inc. Announces Participation at the J.P. Morgan Global Technology, Media and Telecom Conference investment picks
2013/5/2
http://media.marketwire.com/attachments/200802/410334_070212-VISHAYNEWLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1013027&ProfileId=051205&sourceType=1 MALVERN, PA --
Sign-up for Vishay Intertechnology's Tantalum-Cased Wet Tantalum Capacitors for Avionics and Aerospace Now Available With Enhanced Vibration Capability investment picks
2013/5/2
SAN DIEGO , May 2, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC) , a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today reported results for the first quarter of 2013.
Sign-up for Volcano Announces First Quarter Results investment picks
2013/5/2
VORNADO REALTY TRUST (NYSE:VNO) announced today that its Board of Trustees has declared a regular quarterly dividend of $0.73 per share payable on May 23, 2013 to common shareholders of record on May 13, 2013.
Sign-up for Vornado Declares Quarterly $0.73 Dividend on Common Shares investment picks
2013/5/2
DALLAS , May 2, 2013 /PRNewswire/ -- Voyager Learning, the nation's most comprehensive provider of PreK–12 intervention learning solutions and education services, announced today the release of We Can: Early Learning Curriculum, Second Edition, an evidence-based Pre-K curriculum that prepares all children to be academically successful in kindergarten and beyond.
Sign-up for Voyager Learning Launches We Can®: Early Learning Curriculum, Second Edition: We Can prepares all children for success in kindergarten and beyond investment picks
2013/5/2
2013 Outlook for Earnings Improvement on Track Driven by Growth in Private Construction, Improved Pricing and Cost Management BIRMINGHAM, Ala.
Sign-up for Vulcan Announces First Quarter 2013 Results investment picks
2013/5/2
http://media.marketwire.com/attachments/201302/57740_wandiscoLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1013431&ProfileId=051205&sourceType=1 SAN RAMON, CA --
Sign-up for WANdisco's Free Online Hadoop Training Webinars Back by Popular Demand investment picks
2013/5/2
DUBLIN, Ireland, May 2, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Board of Directors has voted unanimously to appoint Paul Herendeen, the Company's Executive Vice President and Chief Financial Officer, to the Company's Board effective as of May 2, 2013.
Sign-up for Warner Chilcott Announces Changes to Board of Directors investment picks
2013/5/2
There’s one surefire way to get face time with Warren Buffett at Berkshire Hathaway’s BRK.A  annual shareholders’ meeting this weekend: Outrun thousands of other shareholders and fans in the company’s inaugural 5K race.
Sign-up for Warren Buffett makes shareholders sweat investment picks
2013/5/2
WASHINGTON (MarketWatch) — President Barack Obama clearly has a soft spot in his heart for Charlotte, N.C., naming two of the city’s prominent politicians to top government posts this week after selecting it as the site of last year’s Democratic convention.
Sign-up for Watt nomination 1st step to fixing Fannie, Freddie investment picks
2013/5/2
Earnings per Share of $0.15 GENEVA, Switzerland , May 2, 2013 /PRNewswire/ -- Weatherford International Ltd.
Sign-up for Weatherford Reports First Quarter 2013 Results investment picks
2013/5/2
First quarter revenue and profitability exceed high end of guidance Added 21,000 net new subscribers, ending the quarter at 3.03 million subscribers Average Revenue Per User of $13.89 grew $0.12 sequentially Completed second debt re-financing increasing total annualized interest savings to $18 million JACKSONVILLE, Fla., May 2, 2013 (GLOBE NEWSWIRE) -- Web.com Group, Inc. (Nasdaq:WWWW) , a leading provider of internet services and online marketing solutions for small businesses, today announced results for the first quarter ended March 31, 2013.
Sign-up for Web.com Reports First Quarter 2013 Financial Results investment picks
2013/5/2
CARLSBAD, Calif.
Sign-up for Webcast Alert: Isis Pharmaceuticals' First Quarter 2013 Financial Results Conference Call investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: USA Technologies Introduces ePort Mobile as a Turnkey Solution for B2B and B2C Transactions at 2013 ETA Annual Meeting and Expo to Webcast Alert: Isis Pharmaceuticals' First Quarter 2013 Financial Results Conference Call
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity